Other Investigators

Julian Falutz
Dr Falutz is involved in several research endeavors related to aging, metabolic complications, and body composition changes in HIV patients. He collaborates with American, Canadian and European investigators on studies of the role of both loss of muscle mass and obesity on clinical and functional outcomes in HIV patients. He was the international co-primary investigator for several multi-national studies of a novel growth-hormone releasing factor, tesamorelin, developed locally in Montreal, which was shown to be effective in reducing visceral adiposity in treated HIV patients with lipodystrophy.
Learn more
Cecilia T. Costiniuk
Dr Costiniuk completed medical school at McMaster University in Hamilton, Ontario. This was followed by training in Internal Medicine and Infectious Diseases at the University of Ottawa, then a Master’s degree in Microbiology and Immunology. Following her Master’s, Dr Costiniuk pursued an HIV research fellowship at the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) in Durban, South Africa and local hospitals. Following her return to Canada, she joined McGill’s Department of Medicine, Division of Infectious Diseases as assistant professor in 2014.
Learn more
Joseph Cox
Dr. Cox graduated in Medicine from Dalhousie University. He completed Public Health and Prevention Medicine post-graduate training at McGill University, during which he completed an MSc in Epidemiology. He is also certified in Addiction Medicine by the American Board of Addiction Medicine. He is currently an attending physician in the STI-Bloodborne Infections & Harm Reduction Team, Infectious Disease Prevention & Control Sector, Montreal Public Health Department, and the Clinical Director of the Chronic Viral Illness Service at the MUHC – Glen Site. Dr. Cox is an Associate Professor in the Department of Epidemiology, Biostatistics and Occupational Health and Associate Member in the Departments of Medicine and Family Medicine at McGill University.
Learn more